Kartan Advancement in the Cancer treatment

Erscheinungsjahr 2020
ISBN: 978-1-77407-989-8
Verlag: Delve Publishing
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 525 Seiten, Electronic book text, Format (B × H): 152 mm x 229 mm

Cancer: It is a disease where our body cells loose ability to divide at normal rate, this abnormal growth of cells results formation of lumps or tumours in body. Depending on the stage of the cancer and condition of the patient, treatment for the disease is decided. Treatment is given either to cure the disease or to shrink the tumour size or slow down the growth of disease allowing patient to live a normal life or live symptom free if possible. General treatment options available for treating cancer include: Surgery, Chemotherapy, Radiation therapy, Immunotherapy. In this book, discusses some of the advances made in the field of cancer treatment.

Autoren/Hrsg.

Kartan, Preethi

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Molekulare Medizin, Zellbiologie
• Naturwissenschaften Biowissenschaften Biowissenschaften

Inhaltsverzeichnis

- Chapter 1: Advances in Cancer Immunotherapy 2019 – Latest Trends
- Chapter 2: Recent Updates in Cancer Immunotherapy: a Comprehensive Review and Perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
- Chapter 3: Next-generation immuno-oncology Agents: Current Momentum Shifts in Cancer Immunotherapy
- Chapter 4: Cancer Immunotherapy beyond Immune Checkpoint Inhibitors
- Chapter 5: Recent Advances in Cancer Immunotherapy
- Chapter 6: Advances on Chimeric Antigen Receptor-modified T-cell Therapy for Oncotherapy
- Chapter 7: Recent Developments in Immunotherapy of Acute Myeloid Leukemia
- Chapter 8: Assessment by miRNA Microarray of an Autologous Cancer Antigen-pulsed Adoptive Immune Ensemble Cell Therapy (AC-ACT) Approach; Demonstrated Induction of Anti-oncogenic and Anti-PD-L1 miRNAs
- Chapter 9: Investigation of Anti-cancer and Migrastatic Properties of Novel Curcumin Derivatives on Breast and Ovarian Cancer Cell Lines
- Chapter 10: Recent Advances in Cancer Therapy Based on Dual Mode Gold Nanoparticles
- Chapter 11: Current Landscape and Future of Dual Anti-CTLA4 and PD-1/PD-L1 Blockade Immunotherapy in Cancer; Lessons Learned from Clinical Trials with Melanoma and Non-small Cell Lung Cancer (NSCLC)
- Chapter 12: PD-1: Its Discovery, Involvement in Cancer Immunotherapy, and Beyond
- Chapter 13: A Current Perspective on Cancer Immune Therapy: Step-by-step Approach to Constructing the Magic Bullet
- Chapter 14: Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology
- Chapter 15: Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy
- Chapter 16: Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
- Chapter 17: Recent Advances on Inorganic Nanoparticle-Based Cancer Therapeutic Agents
- Chapter 18: Recent Advances in Cancer Stem Cell-Targeted Immunotherapy
- Chapter 19: Small Gold Nanorods: Recent Advances in Synthesis, Biological Imaging, and Cancer Therapy
- Chapter 20: A Review of Recent Advances in the Treatment of Elderly and Poor Performance NSCLC
- Chapter 21: Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges